Total Payments
$3,296
2020 Payments
$289.54
Companies
3
Transactions
15
Medicare Patients
4,856
Medicare Billing
$972,483
Payment Breakdown by Category
Gifts$2,895 (87.8%)
Food & Beverage$401.04 (12.2%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Gift | $2,895 | 1 | 87.8% |
| Food and Beverage | $401.04 | 14 | 12.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Allergan Inc. | $2,906 | 2 | $0 (2017) |
| Abbott Laboratories | $375.12 | 12 | $0 (2020) |
| PFIZER INC. | $15.24 | 1 | $0 (2020) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2020 | $289.54 | 12 | Abbott Laboratories ($274.30) |
| 2018 | $100.82 | 1 | Abbott Laboratories ($100.82) |
| 2017 | $2,906 | 2 | Allergan Inc. ($2,906) |
All Payment Transactions
15 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 09/25/2020 | PFIZER INC. | ELIQUIS (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 04/27/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $19.85 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/28/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $154.40 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/28/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $14.25 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/28/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $9.32 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/04/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 02/04/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $9.63 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $9.72 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $8.15 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 01/02/2020 | Abbott Laboratories | Proclaim Family of SCS IPGs (Device) | Food and Beverage | In-kind items and services | $6.42 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 03/19/2018 | Abbott Laboratories | Circulatory Support (Device) | Food and Beverage | In-kind items and services | $100.82 | General |
| Category: Cardiac Arrhythmias and Heart Failure | ||||||
| 08/31/2017 | Allergan Inc. | BOTOX THERAPEUTIC - HH (Biological) | Gift | Cash or cash equivalent | $2,895.00 | General |
| Category: HYPERHYDROSIS | ||||||
| 04/27/2017 | Allergan Inc. | LO LOESTRIN FE (Drug) | Food and Beverage | In-kind items and services | $10.68 | General |
| Category: WOMENS HEALTH | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 7 | 1,991 | 7,125 | $824,776 | $454,076 |
| 2022 | 7 | 2,258 | 6,754 | $795,400 | $404,535 |
| 2021 | 5 | 245 | 650 | $81,868 | $42,918 |
| 2020 | 15 | 362 | 2,990 | $213,592 | $70,954 |
Total Patients
4,856
Total Services
17,519
Medicare Billing
$972,483
Procedure Codes
34
All Medicare Procedures & Services
34 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 758 | 5,798 | $609,080 | $346,184 | 56.8% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 547 | 602 | $119,900 | $58,837 | 49.1% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 179 | 196 | $57,793 | $25,727 | 44.5% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 386 | 406 | $23,223 | $15,187 | 65.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 46 | 46 | $7,159 | $3,972 | 55.5% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2023 | 54 | 54 | $4,137 | $2,099 | 50.7% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 21 | 23 | $3,484 | $2,071 | 59.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 651 | 5,023 | $527,666 | $269,760 | 51.1% |
| 99222 | Initial hospital inpatient care per day, typically 50 minutes | Facility | 2022 | 550 | 605 | $120,498 | $61,492 | 51.0% |
| 99358 | Extended patient service without direct patient contact, first hour | Facility | 2022 | 478 | 523 | $89,113 | $43,642 | 49.0% |
| 99231 | Follow-up hospital inpatient care per day, typically 15 minutes | Facility | 2022 | 337 | 356 | $20,457 | $10,410 | 50.9% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 56 | 58 | $17,102 | $8,787 | 51.4% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 76 | 77 | $11,984 | $6,006 | 50.1% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Facility | 2022 | 110 | 112 | $8,580 | $4,439 | 51.7% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 131 | 495 | $52,000 | $27,301 | 52.5% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 27 | 67 | $10,150 | $5,324 | 52.5% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 32 | 32 | $9,436 | $4,918 | 52.1% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2021 | 35 | 36 | $7,170 | $3,750 | 52.3% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 20 | 20 | $3,113 | $1,625 | 52.2% |
| J7320 | Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg | Office | 2020 | 16 | 2,041 | $30,615 | $23,989 | 78.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 65 | 208 | $40,560 | $13,130 | 32.4% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 41 | 196 | $58,031 | $11,248 | 19.4% |
| 20611 | Aspiration and/or injection of major joint or joint capsule with recording and reporting using ultrasound guidance | Office | 2020 | 22 | 69 | $16,190 | $4,799 | 29.6% |
| 64483 | Injections of anesthetic and/or steroid drug into lower or sacral spine nerve root using imaging guidance | Office | 2020 | 18 | 30 | $15,903 | $4,442 | 27.9% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 15 | 15 | $7,003 | $2,404 | 34.3% |
About Dr. Thirston Phillips, DO
Dr. Thirston Phillips, DO is a Physical Medicine & Rehabilitation healthcare provider based in Little River, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/11/2006. The National Provider Identifier (NPI) number assigned to this provider is 1255366175.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Thirston Phillips, DO has received a total of $3,296 in payments from pharmaceutical and medical device companies, with $289.54 received in 2020. These payments were reported across 15 transactions from 3 companies. The most common payment nature is "Gift" ($2,895).
As a Medicare-enrolled provider, Phillips has provided services to 4,856 Medicare beneficiaries, totaling 17,519 services with total Medicare billing of $972,483. Data is available for 4 years (2020–2023), covering 34 distinct procedure/service records.
Ad
Practice Information
- Specialty Physical Medicine & Rehabilitation
- Location Little River, SC
- Active Since 07/11/2006
- Last Updated 10/27/2021
- Taxonomy Code 208100000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1255366175
Products in Payments
- BOTOX THERAPEUTIC - HH (Biological) $2,895
- Proclaim Family of SCS IPGs (Device) $274.30
- Circulatory Support (Device) $100.82
- ELIQUIS (Drug) $15.24
- LO LOESTRIN FE (Drug) $10.68
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.